http://q13fox.com/2014/09/18/cure-fo...lops-new-drug/

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829467/

https://www.michaeljfox.org/files/ac...hnologyInc.pdf

https://www.michaeljfox.org/foundati...p?grant_id=993

http://www.m3bio.com/m3-blog/category/all

Um, WOW - this sounds super promising. Has anyone heard of this before? I think this is the first I'm hearing of M3 Bio. She mentioned fast tracking it - that would be awesome.
Plus I had no idea that mice can do pull ups.

The Good News: the lead scientists behind this new class of regenerative drugs, at Washington St. Univ. and M3 Biotechnology, believe it will lead to effective treatments for Parkinson's and Alzheimer's. The most compelling aspect of this new technology is that a switch can be turned on and off by M3’s small molecule drugs, which in the case of neurodegenerative disease results in the activation of critical growth factors and the stimulation of regenerative activity. On the flip side, small molecule growth factor inhibitors have proven to be potent anti-cancer agents where growth factor over-activation is nearly universal. Given time and continued investment in its development, this technology has the potential to revolutionize treatment for an array of diseases. Alzheimer’s and Parkinson’s are just the beginning.

The Bad News: They don't see these effective treatments being available for use until 2034, or in about 20 years.

Well, if it actually works, it will be great news for our kids and grandchildren!

http://bit.ly/1nAIhP1

It's so frustrating that something so hopeful will take so long to get to market.